AIIMS CRE 2025
Pharmacology
Easy

Which HIV protein is targeted by entry-inhibiting drugs?

Appeared in: AIIMS CRE 2025

Explanation

  • The HIV protein gp41 is a transmembrane glycoprotein located on the viral envelope.
  • Its primary function is to mediate the fusion of the viral envelope with the host cell's plasma membrane, which is the final step of viral entry.
  • Fusion inhibitors, a key class of entry-inhibiting drugs, specifically bind to gp41.
  • By binding to gp41, these drugs (like enfuvirtide) prevent the conformational changes necessary for membrane fusion, effectively blocking the virus from entering the host cell.

Why Other Options Were Wrong

  • Option A: gp120 is involved in the initial attachment of HIV to the host cell's CD4 receptor, not the fusion step that is the classic target of entry inhibitors like enfuvirtide.
  • Option C: p24 is an internal capsid protein that encloses the viral genetic material. It is not located on the viral surface and therefore cannot be a target for drugs that block entry.
  • Option D: p17 is the matrix protein, an internal structural component that lines the inner surface of the viral envelope. It is not involved in the entry process.

Related Visual

An illustration of the HIV life cycle, highlighting the viral entry step. The diagram should clearly label gp120 attaching to the CD4 receptor and gp41 mediating membrane fusion...
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology of Antiretroviral Drugs as background academic context rather than a clinical decision trigger.
  • Entry inhibitors are often reserved for treatment-experienced patients who have developed resistance to other classes of antiretroviral therapy (ART).
  • A key nursing role is patient education on the administration of entry inhibitors like enfuvirtide, which is given by subcutaneous injection and can cause significant injection-site reactions.
  • What if the patient's virus shows a tropism for CXCR4 instead of CCR5? This is relevant for another type of entry inhibitor, CCR5 antagonists (like maraviroc), which block the host cell co-receptor. If the virus uses CXCR4, maraviroc would be ineffective, but a fusion inhibitor targeting gp41 would still be a potential option as its mechanism is independent of co-receptor type.
How to Approach the Question
  • First, identify the core of the question: it asks for the specific HIV protein targeted by 'entry-inhibiting drugs'.
  • Recall the structure of the HIV virus, differentiating between external envelope proteins (gp120, gp41) and internal proteins (p24, p17).
  • Understand that drugs blocking entry must target surface proteins.
  • Differentiate the roles of the two surface proteins: gp120 is for attachment, and gp41 is for fusion.
  • Recall the major classes of entry inhibitors. Fusion inhibitors are a classic example that targets a viral protein.
  • Connect the fusion inhibitor class to its specific target, gp41, to select the best answer among the choices.
Concept Tested & Keywords
  • Concept Tested: Pharmacology of Antiretroviral Drugs
  • Stem keywords: HIV protein, entry-inhibiting drugs
  • Lead-in keywords: Which

Question ID

QdcBq1FWw_57AEhWKJWnPX

Reference Book

E6 Pathology-Textbook of PATHOLOGYHarsh Mohan Part 1 (1-214) p. 152-154

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 2094-2096

E6 Robert Boland, Marcia L. Verduin - Kaplan and Sadock's Comprehensive Text of Psychiatry-Wolters Kluwer Health (2024) (pp 1-16525 of 16525) p. 1942-1944

Practise the full AIIMS CRE 2025

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Antimicrobial Drugs Questions

More AIIMS CRE 2025 Questions